REVUMENIB

REVUMENIB was reported 1031 times

REVUMENIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SALVAGE THERAPY 1 0.1667
1 IMMUNOCHEMOTHERAPY 1 0.1250
2 ANTIFUNGAL TREATMENT 1 0.1250
3 CD3 LYMPHOCYTES DECREASED 1 0.0909
4 DIFFERENTIATION SYNDROME 47 0.0640
5 PLASMA CELLS DECREASED 2 0.0400
6 DONOR LEUKOCYTE INFUSION 1 0.0385
7 LINEAGE SWITCH LEUKAEMIA 2 0.0377
8 CARDIOVASCULAR FUNCTION TEST ABNORMAL 1 0.0370
9 TURBINECTOMY 1 0.0263
10 GRANULICATELLA INFECTION 1 0.0238
11 BIOPSY BONE MARROW 11 0.0235
12 PARAINFLUENZA VIRUS INFECTION 2 0.0194
13 NUTRITIONAL SUPPLEMENTATION 1 0.0167
14 ELECTROCARDIOGRAM 1 0.0164
15 CHEST CRUSHING 1 0.0156
16 BLAST CELL COUNT DECREASED 1 0.0137
17 LEUKAEMIA RECURRENT 22 0.0130
18 PLATELET TRANSFUSION 16 0.0124
19 HAEMOGLOBINAEMIA 2 0.0117
20 SWELLING OF NOSE 2 0.0116
21 BONE MARROW TRANSPLANT 22 0.0116
22 TRANSPLANT 26 0.0109
23 LARYNGEAL INFLAMMATION 2 0.0106
24 TRANSFUSION RELATED COMPLICATION 1 0.0090
25 PROSTATIC SPECIFIC ANTIGEN DECREASED 3 0.0079
26 LUMBAR PUNCTURE 3 0.0079
27 PERICARDITIS INFECTIVE 1 0.0072
28 LYMPHOCYTE ADOPTIVE THERAPY 2 0.0072
29 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
30 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 3 0.0060
31 BLOOD ZINC DECREASED 1 0.0055
32 BIOPSY 5 0.0054
33 CHEMOTHERAPY 19 0.0050
34 RED BLOOD CELL TRANSFUSION 2 0.0049
35 VITAL FUNCTIONS ABNORMAL 4 0.0047
36 RENAL NECROSIS 1 0.0046
37 PARENTERAL NUTRITION 1 0.0043
38 MOLE EXCISION 1 0.0041
39 ACUTE MYELOMONOCYTIC LEUKAEMIA 1 0.0040
40 BLAST CELL COUNT INCREASED 4 0.0038
41 CATHETER SITE THROMBOSIS 1 0.0036
42 STEM CELL TRANSPLANT 8 0.0032
43 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
44 FLUID REPLACEMENT 1 0.0030
45 ANOXIA 1 0.0028
46 DERMATITIS DIAPER 2 0.0028
47 ACUTE MYELOID LEUKAEMIA RECURRENT 6 0.0028
48 INVESTIGATION ABNORMAL 4 0.0028
49 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
50 MUSCLE DISCOMFORT 2 0.0025
51 FULL BLOOD COUNT DECREASED 49 0.0024
52 GLOMERULAR FILTRATION RATE INCREASED 2 0.0024
53 GASTROINTESTINAL TUBE INSERTION 6 0.0024
54 STARVATION 2 0.0024
55 VOLUME BLOOD DECREASED 1 0.0024
56 ENTEROVIRUS INFECTION 2 0.0023
57 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
58 NEUTROPHIL COUNT ABNORMAL 6 0.0021
59 MINIMAL RESIDUAL DISEASE 1 0.0021
60 RED BLOOD CELL COUNT ABNORMAL 3 0.0020
61 MYELOID LEUKAEMIA 1 0.0020
62 INFANTILE SPITTING UP 1 0.0019
63 TRANSFUSION 20 0.0019
64 BONE CANCER METASTATIC 1 0.0019
65 FULL BLOOD COUNT ABNORMAL 20 0.0019
66 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
67 IRON OVERLOAD 2 0.0019
68 GASTROINTESTINAL BACTERIAL INFECTION 2 0.0017
69 ENTERAL NUTRITION 1 0.0017
70 HOSPICE CARE 17 0.0017
71 FULL BLOOD COUNT INCREASED 2 0.0017
72 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
73 RENAL SURGERY 1 0.0015
74 ANISOCYTOSIS 1 0.0015
75 GINGIVAL DISCOMFORT 1 0.0015
76 ORAL MUCOSAL DISCOLOURATION 1 0.0015
77 PLATELET COUNT DECREASED 160 0.0015
78 THERAPEUTIC PROCEDURE 2 0.0014
79 ANTIBODY TEST ABNORMAL 1 0.0014
80 ELECTROCARDIOGRAM QT PROLONGED 49 0.0014
81 DEBRIDEMENT 1 0.0013
82 RETINAL INJURY 1 0.0013
83 LABORATORY TEST ABNORMAL 37 0.0013
84 VASCULAR ACCESS COMPLICATION 1 0.0012
85 TASTE DISORDER 25 0.0012
86 HAEMATOLOGICAL INFECTION 3 0.0012
87 CYTOPENIA 15 0.0012
88 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
89 PLATELET DISORDER 3 0.0012
90 REGURGITATION 4 0.0012
91 BLOOD MAGNESIUM DECREASED 10 0.0012
92 PLATELET COUNT ABNORMAL 7 0.0012
93 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
94 TRANSFUSION REACTION 1 0.0011
95 BLOOD MAGNESIUM INCREASED 1 0.0011
96 VASCULAR DEVICE INFECTION 5 0.0011
97 LYMPH NODE PAIN 2 0.0011
98 ENDOTRACHEAL INTUBATION 3 0.0011
99 BLOOD IRON INCREASED 2 0.0011
100 ELECTROCARDIOGRAM CHANGE 1 0.0011
101 RADIOTHERAPY 2 0.0010
102 RHINOVIRUS INFECTION 4 0.0010
103 ANTIBIOTIC THERAPY 1 0.0010
104 NEUTROPHIL COUNT DECREASED 41 0.0010
105 CENTRAL VENOUS CATHETERISATION 3 0.0010
106 RECURRENT CANCER 4 0.0010
107 GRAFT VERSUS HOST DISEASE 7 0.0010
108 SUPERFICIAL INJURY OF EYE 1 0.0009
109 METHAEMOGLOBINAEMIA 2 0.0009
110 FEBRILE INFECTION 1 0.0008
111 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
112 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
113 JOINT WARMTH 1 0.0008
114 VENOOCCLUSIVE DISEASE 2 0.0008
115 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
116 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
117 SERUM FERRITIN INCREASED 4 0.0008
118 EXTRADURAL HAEMATOMA 1 0.0008
119 LEUKAEMIA 7 0.0007
120 RED BLOOD CELL COUNT DECREASED 21 0.0007
121 BLOOD PHOSPHORUS INCREASED 2 0.0007
122 ABSCESS ORAL 1 0.0007
123 ESCHERICHIA INFECTION 6 0.0007
124 ECHOCARDIOGRAM ABNORMAL 1 0.0007
125 INTENSIVE CARE 1 0.0007
126 NOROVIRUS INFECTION 1 0.0007
127 WHITE BLOOD CELL COUNT DECREASED 73 0.0007
128 DISEASE COMPLICATION 3 0.0007
129 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
130 SINUS ARREST 1 0.0006
131 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
132 BACTERIAL SEPSIS 2 0.0006
133 SPLENIC RUPTURE 1 0.0006
134 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
135 ELECTROLYTE IMBALANCE 7 0.0006
136 NEOPLASM RECURRENCE 2 0.0006
137 SEIZURE LIKE PHENOMENA 1 0.0006
138 SLUGGISHNESS 6 0.0006
139 BLOOD PHOSPHORUS DECREASED 2 0.0005
140 VENTRICULAR ARRHYTHMIA 2 0.0005
141 BLOOD POTASSIUM DECREASED 16 0.0005
142 REHABILITATION THERAPY 2 0.0005
143 ACUTE MYELOID LEUKAEMIA 8 0.0005
144 UNDERWEIGHT 1 0.0005
145 PNEUMONIA FUNGAL 2 0.0005
146 BACTERAEMIA 6 0.0005
147 HAEMOGLOBIN DECREASED 51 0.0005
148 FRUSTRATION TOLERANCE DECREASED 4 0.0005
149 BODY TEMPERATURE FLUCTUATION 1 0.0005
150 LUNG ABSCESS 1 0.0005
151 SLEEP DEFICIT 1 0.0005
152 HAEMOGLOBIN ABNORMAL 3 0.0005
153 CORONAVIRUS INFECTION 3 0.0005
154 GINGIVAL SWELLING 2 0.0005
155 FAECES PALE 1 0.0004
156 BRAIN FOG 7 0.0004
157 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
158 LIP DRY 4 0.0004
159 THROMBOCYTOPENIA 49 0.0004
160 PANCREATITIS NECROTISING 1 0.0004
161 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
162 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
163 ORAL SURGERY 1 0.0004
164 INGROWING NAIL 1 0.0004
165 WRONG DOSE 1 0.0004
166 SLOW SPEECH 1 0.0004
167 PRODUCT DOSE OMISSION ISSUE 121 0.0004
168 BREATH ODOUR 1 0.0004
169 TRANSPLANT FAILURE 1 0.0004
170 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
171 HEPATIC ENZYME ABNORMAL 2 0.0004
172 PAROSMIA 3 0.0004
173 BRAIN ABSCESS 1 0.0004
174 MEAN CELL VOLUME INCREASED 1 0.0004
175 HERNIA REPAIR 1 0.0004
176 PERSONALITY DISORDER 1 0.0004
177 ANIMAL BITE 1 0.0004
178 BACTERIAL INFECTION 7 0.0004
179 BLOOD POTASSIUM ABNORMAL 1 0.0004
180 ANAL FISSURE 2 0.0004
181 BLOOD POTASSIUM INCREASED 6 0.0004
182 ELECTRIC SHOCK SENSATION 1 0.0004
183 PROCTITIS 1 0.0004
184 BLOOD TEST ABNORMAL 5 0.0004
185 OFF LABEL USE 310 0.0004
186 VITAMIN B12 DECREASED 1 0.0003
187 ESCHERICHIA SEPSIS 1 0.0003
188 PULMONARY PAIN 1 0.0003
189 ODYNOPHAGIA 2 0.0003
190 CHEST X-RAY ABNORMAL 1 0.0003
191 DISEASE PROGRESSION 38 0.0003
192 BLOOD CREATININE DECREASED 1 0.0003
193 PRODUCT USE COMPLAINT 5 0.0003
194 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
195 THERAPY CHANGE 3 0.0003
196 LISTLESS 1 0.0003
197 APPETITE DISORDER 2 0.0003
198 SUDDEN CARDIAC DEATH 1 0.0003
199 WOUND COMPLICATION 1 0.0003
200 ILLNESS 30 0.0003
201 PETECHIAE 3 0.0003
202 EATING DISORDER 6 0.0003
203 FAECES SOFT 2 0.0003
204 ORAL DISORDER 2 0.0003
205 LEUKOENCEPHALOPATHY 1 0.0003
206 IMMUNODEFICIENCY 4 0.0003
207 MALNUTRITION 3 0.0003
208 GINGIVAL DISORDER 1 0.0003
209 DEVICE RELATED INFECTION 4 0.0003
210 MUSCULOSKELETAL CHEST PAIN 4 0.0003
211 FAECES HARD 1 0.0003
212 MULTIPLE ALLERGIES 2 0.0003
213 POLYDIPSIA 1 0.0003
214 MYELOSUPPRESSION 9 0.0002
215 CYSTITIS HAEMORRHAGIC 1 0.0002
216 GALLBLADDER OPERATION 1 0.0002
217 LEG AMPUTATION 1 0.0002
218 HEPATIC LESION 1 0.0002
219 HORDEOLUM 1 0.0002
220 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
221 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
222 MELANOCYTIC NAEVUS 1 0.0002
223 IMMUNOSUPPRESSION 2 0.0002
224 GASTROINTESTINAL INFECTION 2 0.0002
225 SUSPECTED OFF LABEL USE 1 0.0002
226 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
227 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
228 NAUSEA 172 0.0002
229 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
230 PERICARDIAL EFFUSION 5 0.0002
231 ROSACEA 1 0.0002
232 SKIN ABRASION 1 0.0002
233 FEBRILE NEUTROPENIA 14 0.0002
234 FUNGAL INFECTION 7 0.0002
235 GASTROINTESTINAL TOXICITY 1 0.0002
236 ENTEROCOCCAL INFECTION 1 0.0002
237 SINUS BRADYCARDIA 2 0.0002
238 LIGAMENT SPRAIN 2 0.0002
239 DYSGEUSIA 15 0.0002
240 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
241 HAEMORRHAGE INTRACRANIAL 3 0.0002
242 RESPIRATORY DISORDER 6 0.0002
243 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
244 VULVOVAGINAL PRURITUS 1 0.0002
245 SUBARACHNOID HAEMORRHAGE 2 0.0002
246 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
247 INFECTION 28 0.0002
248 RENAL DISORDER 9 0.0002
249 BLOOD LACTIC ACID INCREASED 1 0.0002
250 PERIPHERAL SWELLING 29 0.0002
251 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
252 LIVER FUNCTION TEST INCREASED 4 0.0002
253 PRODUCT SIZE ISSUE 1 0.0002
254 ANAL ABSCESS 1 0.0002
255 GINGIVITIS 1 0.0002
256 STRESS FRACTURE 1 0.0002
257 HYDROCEPHALUS 1 0.0002
258 PYREXIA 63 0.0002
259 ASTHENOPIA 1 0.0002
260 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
261 STREPTOCOCCAL INFECTION 1 0.0002
262 HEART RATE ABNORMAL 1 0.0002
263 BLOOD UREA INCREASED 3 0.0002
264 FLUID RETENTION 9 0.0002
265 PERIORBITAL SWELLING 1 0.0002
266 HYPERSOMNIA 5 0.0002
267 BLOOD URIC ACID INCREASED 1 0.0002
268 MADAROSIS 2 0.0002
269 RALES 1 0.0002
270 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
271 BRADYKINESIA 1 0.0002
272 NEUTROPENIA 23 0.0002
273 DECREASED APPETITE 39 0.0002
274 CEREBRAL HAEMORRHAGE 6 0.0002
275 GASTROENTERITIS VIRAL 3 0.0002
276 LOCALISED INFECTION 4 0.0002
277 STOMATITIS 10 0.0002
278 VOMITING 77 0.0002
279 ADVERSE EVENT 15 0.0002
280 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
281 OLIGURIA 1 0.0002
282 TOOTH EXTRACTION 2 0.0002
283 AGEUSIA 4 0.0002
284 BLOOD SODIUM DECREASED 3 0.0002
285 CARDIAC FLUTTER 1 0.0002
286 WALKING AID USER 1 0.0002
287 SARS-COV-2 TEST POSITIVE 2 0.0002
288 BLOOD PRESSURE ABNORMAL 3 0.0002
289 EAR INFECTION 4 0.0002
290 SKIN MASS 1 0.0001
291 TERMINAL STATE 1 0.0001
292 ABDOMINAL DISCOMFORT 25 0.0001
293 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
294 MOOD ALTERED 4 0.0001
295 GINGIVAL BLEEDING 2 0.0001
296 HAIR GROWTH ABNORMAL 1 0.0001
297 MEDICATION ERROR 8 0.0001
298 HYPERTRANSAMINASAEMIA 1 0.0001
299 PRODUCT USE ISSUE 27 0.0001
300 PANCYTOPENIA 8 0.0001
301 FATIGUE 110 0.0001
302 PRODUCT SUPPLY ISSUE 1 0.0001
303 CELLULITIS 7 0.0001
304 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
305 SENSITIVE SKIN 1 0.0001
306 PULMONARY MASS 2 0.0001
307 ORAL PAIN 3 0.0001
308 DEPRESSED MOOD 7 0.0001
309 OSTEOPENIA 2 0.0001
310 TROPONIN INCREASED 1 0.0001
311 INSURANCE ISSUE 2 0.0001
312 HYPOALBUMINAEMIA 1 0.0001
313 THERAPY PARTIAL RESPONDER 2 0.0001
314 HAEMORRHAGIC STROKE 1 0.0001
315 PULMONARY HAEMORRHAGE 1 0.0001
316 TORSADE DE POINTES 1 0.0001
317 AFFECTIVE DISORDER 1 0.0001
318 FURUNCLE 1 0.0001
319 DISEASE RECURRENCE 6 0.0001
320 BLINDNESS 5 0.0001
321 POLYURIA 1 0.0001
322 HICCUPS 1 0.0001
323 DEATH 104 0.0001
324 HEMIPLEGIA 1 0.0001
325 GAIT INABILITY 4 0.0001
326 UNEVALUABLE EVENT 9 0.0001
327 MYALGIA 20 0.0001
328 HEPATIC ENZYME INCREASED 8 0.0001
329 HYPOPHAGIA 3 0.0001
330 THERAPY CESSATION 6 0.0001
331 CARDIAC OPERATION 1 0.0001
332 SKIN SWELLING 1 0.0001
333 SEPTIC SHOCK 5 0.0001
334 URINE OUTPUT DECREASED 1 0.0001
335 MYOSITIS 1 0.0001
336 PANIC ATTACK 4 0.0001
337 BRAIN NEOPLASM 1 0.0001
338 MENTAL STATUS CHANGES 3 0.0001
339 PRODUCT DISTRIBUTION ISSUE 1 0.0001
340 BLOOD CREATININE INCREASED 7 0.0001
341 APPENDICITIS 1 0.0001
342 OXYGEN SATURATION DECREASED 6 0.0001
343 ARTERIOSCLEROSIS 1 0.0001
344 AFFECT LABILITY 1 0.0001
345 HEPATOMEGALY 1 0.0001
346 KNEE OPERATION 1 0.0001
347 DYSPEPSIA 10 0.0001
348 BODY TEMPERATURE DECREASED 1 0.0001
349 SALIVARY HYPERSECRETION 1 0.0001
350 FEEDING DISORDER 2 0.0001
351 BONE MARROW FAILURE 2 0.0001
352 NEUTROPHIL COUNT INCREASED 1 0.0001
353 EUPHORIC MOOD 1 0.0001
354 EMOTIONAL DISORDER 3 0.0001
355 HYPERBILIRUBINAEMIA 1 0.0001
356 VENTRICULAR EXTRASYSTOLES 1 0.0001
357 WEIGHT FLUCTUATION 1 0.0001
358 MOUTH ULCERATION 2 0.0001
359 SCRATCH 1 0.0001
360 INCONTINENCE 1 0.0001
361 EPISTAXIS 7 0.0001
362 POOR QUALITY SLEEP 2 0.0001
363 CONSTIPATION 20 0.0001
364 ASPIRATION 1 0.0001
365 LIVER DISORDER 4 0.0001
366 VIRAL INFECTION 3 0.0001
367 VENTRICULAR FIBRILLATION 1 0.0001
368 PULMONARY OEDEMA 4 0.0001
369 OCULAR DISCOMFORT 1 0.0001
370 ADVERSE DRUG REACTION 8 0.0001
371 ANGER 3 0.0001
372 MICTURITION URGENCY 1 0.0001
373 CHOLECYSTECTOMY 1 0.0001
374 HERPES ZOSTER 5 0.0001
375 THROMBOSIS 7 0.0001
376 NEOPLASM 1 0.0001
377 NEOPLASM PROGRESSION 3 0.0001
378 HAEMORRHAGE 9 0.0001
379 HEART RATE DECREASED 3 0.0001
380 SPLENOMEGALY 1 0.0001
381 LYMPHADENOPATHY 3 0.0001
382 BLOOD IRON DECREASED 1 0.0001
383 ASTHENIA 31 0.0001
384 CARDIOMEGALY 1 0.0001
385 INFLUENZA 9 0.0001
386 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
387 HEPATIC FUNCTION ABNORMAL 3 0.0001
388 ARTHRALGIA 33 0.0001
389 MUSCLE ATROPHY 1 0.0001
390 ROTATOR CUFF SYNDROME 1 0.0001
391 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
392 INFLAMMATION 4 0.0001
393 DIARRHOEA 50 0.0001
394 RHINORRHOEA 5 0.0001
395 PNEUMONIA 25 0.0001
396 PLATELET COUNT INCREASED 1 0.0001
397 BEDRIDDEN 1 0.0001
398 DYSMENORRHOEA 1 0.0001
399 ADVERSE REACTION 1 0.0001
400 DEHYDRATION 10 0.0001
401 EYE HAEMORRHAGE 1 0.0001
402 SWELLING 7 0.0001
403 HAIR TEXTURE ABNORMAL 1 0.0001
404 CONFUSIONAL STATE 12 0.0001
405 FREQUENT BOWEL MOVEMENTS 2 0.0001
406 PRODUCT TASTE ABNORMAL 1 0.0001
407 OEDEMA 4 0.0001
408 ANAEMIA 14 0.0001
409 IMPAIRED GASTRIC EMPTYING 1 0.0001
410 PERIPHERAL COLDNESS 1 0.0001
411 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
412 ABNORMAL DREAMS 2 0.0001
413 POLLAKIURIA 3 0.0001
414 HYPOMAGNESAEMIA 1 0.0001
415 HUNGER 1 0.0001
416 COORDINATION ABNORMAL 1 0.0001
417 MASS 1 0.0001
418 CARPAL TUNNEL SYNDROME 1 0.0001
419 DEVICE OCCLUSION 1 0.0001
420 SEASONAL ALLERGY 1 0.0001
421 PAIN IN JAW 2 0.0001
422 MUSCULAR WEAKNESS 8 0.0001
423 INCORRECT DOSE ADMINISTERED 16 0.0001
424 THERAPY INTERRUPTED 5 0.0001
425 SUBDURAL HAEMATOMA 1 0.0001
426 LETHARGY 4 0.0001
427 PARAESTHESIA ORAL 1 0.0001
428 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
429 BONE PAIN 4 0.0001
430 SURGERY 4 0.0001
431 GASTROINTESTINAL DISORDER 6 0.0001
432 HYPOAESTHESIA ORAL 1 0.0001
433 JOINT SWELLING 8 0.0001
434 PLEURAL EFFUSION 4 0.0001
435 THYROID DISORDER 1 0.0001
436 CARDIAC DISORDER 6 0.0001
437 DRUG-INDUCED LIVER INJURY 2 0.0001
438 DYSPHAGIA 6 0.0001
439 DRUG INTERACTION 10 0.0001
440 ULCER 1 0.0001
441 MOOD SWINGS 2 0.0001
442 FEELING ABNORMAL 15 0.0001
443 HEADACHE 39 0.0001
444 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
445 ALOPECIA 12 0.0001
446 STAPHYLOCOCCAL INFECTION 2 0.0001
447 CARDIAC ARREST 5 0.0001
448 DRUG LEVEL INCREASED 1 0.0001
449 COAGULOPATHY 1 0.0001
450 NASOPHARYNGITIS 11 0.0001
451 ORTHOSTATIC HYPOTENSION 1 0.0001
452 HYPERKALAEMIA 2 0.0001
453 COLD SWEAT 1 0.0001
454 SLEEP DISORDER 4 0.0001
455 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
456 HEAD DISCOMFORT 1 0.0001
457 THIRST 1 0.0001
458 GOUT 1 0.0001
459 LEUKOCYTOSIS 1 0.0001
460 TOOTHACHE 1 0.0001
461 OSTEOMYELITIS 1 0.0001
462 UNDERDOSE 4 0.0001
463 AGRANULOCYTOSIS 1 0.0001
464 SEPSIS 6 0.0001
465 WEIGHT INCREASED 12 0.0001
466 BLOOD URINE PRESENT 1 0.0001
467 PROTEINURIA 1 0.0001
468 NEUROPATHY PERIPHERAL 5 0.0001
469 DRY SKIN 7 0.0001
470 INCREASED APPETITE 1 0.0001
471 DIZZINESS 26 0.0001
472 HOSPITALISATION 8 0.0001
473 GLAUCOMA 1 0.0001
474 ERUCTATION 1 0.0001
475 EAR PAIN 1 0.0001
476 HAEMORRHOIDS 1 0.0001
477 MEMORY IMPAIRMENT 7 0.0001
478 HEART RATE INCREASED 5 0.0001
479 HAEMATOCRIT DECREASED 1 0.0001
480 SPINAL FRACTURE 1 0.0000
481 HYPOTENSION 10 0.0000
482 CARDIAC FAILURE 4 0.0000
483 PRODUCT PHYSICAL ISSUE 1 0.0000
484 PRODUCT ADMINISTRATION ERROR 1 0.0000
485 DRY MOUTH 4 0.0000
486 BODY TEMPERATURE INCREASED 1 0.0000
487 ABDOMINAL PAIN UPPER 10 0.0000
488 ROAD TRAFFIC ACCIDENT 2 0.0000
489 DYSPNOEA 27 0.0000
490 PAIN IN EXTREMITY 14 0.0000
491 RECTAL HAEMORRHAGE 2 0.0000
492 THERAPY NON-RESPONDER 2 0.0000
493 HEART RATE IRREGULAR 1 0.0000
494 SEIZURE 5 0.0000
495 OROPHARYNGEAL PAIN 4 0.0000
496 COUGH 12 0.0000
497 ARRHYTHMIA 2 0.0000
498 PRODUCT PRESCRIBING ERROR 1 0.0000
499 PRODUCTIVE COUGH 2 0.0000
500 BLOOD PRESSURE FLUCTUATION 1 0.0000
501 RESPIRATORY FAILURE 3 0.0000
502 NEURALGIA 1 0.0000
503 ATRIAL FIBRILLATION 4 0.0000
504 OEDEMA PERIPHERAL 5 0.0000
505 SOMNOLENCE 8 0.0000
506 PRODUCT COMPLAINT 1 0.0000
507 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
508 SINUSITIS 4 0.0000
509 DRUG RESISTANCE 1 0.0000
510 DIPLOPIA 1 0.0000
511 RESPIRATORY TRACT INFECTION 1 0.0000
512 ABDOMINAL DISTENSION 4 0.0000
513 MUSCULOSKELETAL PAIN 2 0.0000
514 PARAESTHESIA 6 0.0000
515 HYPERTENSION 8 0.0000
516 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
517 LIMB INJURY 1 0.0000
518 PALLOR 1 0.0000
519 MALAISE 16 0.0000
520 DIVERTICULITIS 1 0.0000
521 HAEMOPTYSIS 1 0.0000
522 FLATULENCE 2 0.0000
523 BALANCE DISORDER 3 0.0000
524 RASH 15 0.0000
525 PALPITATIONS 4 0.0000
526 CHILLS 4 0.0000
527 NASAL CONGESTION 2 0.0000
528 ACUTE MYOCARDIAL INFARCTION 1 0.0000
529 PSYCHOTIC DISORDER 1 0.0000
530 HYPOAESTHESIA 5 0.0000
531 IRRITABILITY 2 0.0000
532 THERAPEUTIC RESPONSE DECREASED 2 0.0000
533 VERTIGO 2 0.0000
534 FEELING HOT 2 0.0000
535 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
536 CHEST PAIN 6 0.0000
537 LIMB DISCOMFORT 1 0.0000
538 NERVOUS SYSTEM DISORDER 1 0.0000
539 SWOLLEN TONGUE 1 0.0000
540 MIGRAINE 3 0.0000
541 CYSTITIS 1 0.0000
542 LOSS OF CONSCIOUSNESS 4 0.0000
543 CONTUSION 3 0.0000
544 DRUG INTOLERANCE 3 0.0000
545 NIGHT SWEATS 1 0.0000
546 LACTIC ACIDOSIS 1 0.0000
547 DEEP VEIN THROMBOSIS 2 0.0000
548 OSTEONECROSIS 1 0.0000
549 INFUSION RELATED REACTION 2 0.0000
550 SYNCOPE 3 0.0000
551 EYE PRURITUS 1 0.0000
552 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
553 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
554 CHEST DISCOMFORT 3 0.0000
555 HAEMATURIA 1 0.0000
556 DELIRIUM 1 0.0000
557 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
558 MOBILITY DECREASED 2 0.0000
559 PAIN 17 0.0000
560 ACCIDENTAL OVERDOSE 1 0.0000
561 MUSCLE SPASMS 5 0.0000
562 DYSURIA 1 0.0000
563 EYE SWELLING 1 0.0000
564 DRUG INEFFECTIVE 35 0.0000
565 HALLUCINATION 2 0.0000
566 INTESTINAL OBSTRUCTION 1 0.0000
567 COLITIS 1 0.0000
568 BLOOD PRESSURE INCREASED 4 0.0000
569 ARTHRITIS 2 0.0000
570 WEIGHT DECREASED 7 0.0000
571 TREMOR 4 0.0000
572 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
573 URINARY TRACT INFECTION 4 0.0000
574 HYPOACUSIS 1 0.0000
575 VAGINAL HAEMORRHAGE 1 0.0000
576 MENTAL DISORDER 1 0.0000
577 RENAL FAILURE 3 0.0000
578 INSOMNIA 6 0.0000
579 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
580 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
581 TINNITUS 1 0.0000
582 HYPOKALAEMIA 1 0.0000
583 BACK PAIN 5 0.0000
584 BLOOD CHOLESTEROL INCREASED 1 0.0000
585 FALL 7 0.0000
586 COMA 1 0.0000
587 DRY EYE 1 0.0000
588 LEUKOPENIA 1 0.0000
589 AGGRESSION 1 0.0000
590 ERYTHEMA 4 0.0000
591 ECZEMA 1 0.0000
592 DISTURBANCE IN ATTENTION 1 0.0000
593 PRURITUS 7 0.0000
594 ANXIETY 5 0.0000
595 DISCOMFORT 1 0.0000
596 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
597 VISUAL IMPAIRMENT 2 0.0000
598 GAIT DISTURBANCE 3 0.0000
599 SWELLING FACE 1 0.0000
600 BURNING SENSATION 1 0.0000
601 SKIN BURNING SENSATION 1 0.0000
602 BRONCHITIS 1 0.0000
603 CARDIAC FAILURE CONGESTIVE 1 0.0000
604 INFLUENZA LIKE ILLNESS 1 0.0000
605 TREATMENT FAILURE 1 0.0000
606 URTICARIA 2 0.0000
607 RENAL IMPAIRMENT 1 0.0000
608 TOXICITY TO VARIOUS AGENTS 2 0.0000
609 COVID-19 2 0.0000
610 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
611 HYPERSENSITIVITY 2 0.0000
612 PULMONARY EMBOLISM 1 0.0000
613 FLUSHING 1 0.0000
614 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
615 EMOTIONAL DISTRESS 1 0.0000
616 VISION BLURRED 1 0.0000
617 ACUTE KIDNEY INJURY 1 0.0000
618 CEREBROVASCULAR ACCIDENT 1 0.0000
619 NO ADVERSE EVENT 1 0.0000
620 BLOOD GLUCOSE INCREASED 1 0.0000
621 OVERDOSE 1 0.0000
622 DEPRESSION 1 0.0000
623 ABDOMINAL PAIN 1 0.0000
624 CONDITION AGGRAVATED 1 0.0000